Skip to main content
. 2024 Jan 26;15:1327770. doi: 10.3389/fimmu.2024.1327770

Table 1.

Socio-demographic characteristics of the female participants (birth cohort 2001) per sampling moment.

Study round (time since vaccination) R1
(Mo 1)
R2 (Mo 6) R3
(Y 1.5)
R4
(Y 2.5)
R5
(Y 3.5)
R6
(Y 4.5)
R7
(Y 5.5)
R8
(Y 6.5)
R9
(Y 7.5)
Participation (n = 56) complete 55 54 52 45 47 47 30 32 31
Blood only 0 0 1 3 2 1 1 4 2
Questionnaire only 0 1 2 0 1 1 10 1 2
Calendar year 2014 2015 2016 2017 2018 2019 2020 2021 2022
Age (median, range) 13,
12-13
13,
13-14
14,
14-15
15,
15-16
16,
16-17
17,
17-18
18,
18-19
19,
19-20
20,
20-21
Ethnicity (% Dutch) 48 (81.4) 48 (81.4) 48 (81.4) 41 (91.1) 39 (90.8) 37 (90.3) 33 (91.7) 27 (93.1) 23 (95.8)
Current educational level*
High 29 (52.7) 29 (52.7) 29 (53.7) 22 (48.9) 25 (52.1) 25 (56.8) 18 (51.4) 20 (69.0) 22 (75.9)
Middle 18 (32.7) 20 (36.4) 21 (38.9) 18 (40.0) 19 (39.6) 19 (43.2) 17 (48.6) 9
(31.0)
7
(24.1)
Low 8 (14.6) 6 (10.9) 4 (7.4) 5 (11.1) 4 (8.3) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
Ever had sex (% yes) 0 (0.0) 0 (0.0) 0
(0.0)
5
(11.1)
12 (25.0) 18 (38.3) 24 (60.0) 23 (69.7) 26 (78.8)
Age sexual debut among sexually active participants (median, range) N/A N/A N/A 15, 14-15 15, 15-16 16, 14-17 16, 14-19 16, 13-19 17, 15-20
Ever used contraception (% yes) 4
(7.3)
5
(9.0)
9
(16.7)
17 (37.8) 26 (53.1) 32 (66.7) 30 (76.9) 29 (82.9) 29 (93.6)
Underlying illness (% yes) 2 (3.6) 3 (5.5) 4 (7.4) 2 (4.4) 5 (10.4) 5 (10.4) 2 (5.0) 2 (6.1) 3 (9.1)
Immunosuppressive medication (% yes) 1 (1.9) 0 (0.0) 0 (0.0) 1 (2.3) 0 (0.0) 2 (4.3) 0 (0.0) 0 (0.0) 2 (6.3)
Had menarche (% yes) 39 (70.9) 46 (83.6) 51 (94.4) 45 (100) 48 (100) 48 (100) 40 (100) 33 (100) 33 (100)

Mo, Month; Y, Year; N/A, Not applicable.

* Low = primary or lower general vocational secondary education; Middle = intermediate vocational secondary education; High = higher vocational/general secondary education, (pre)university education.